Genmab — November 2016
-
"Selv finanshuset HSBC, hvis kursmål ligger et godt stykke under den aktuelle kurs, er blevet en kende mere optimistiske på aktien og har været ude og rykke kursmålet op til 640 kr. fra 613 kr., fremgår det af Reuters. Anbefalingen er dog fortsat reducer." - Ritzau
-
Den opjustering må være pga dollarkursen.

-
vi kunne ikke håbe på bedre
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind